RECITALS:Exclusive License • April 15th, 2005 • Optigenex Inc. • Medicinal chemicals & botanical products • New Jersey
EXCLUSIVE-LICENSEExclusive-License • May 31st, 2022
THIS AGREEMENT, made and entered into on the {CONTRACT_DATE} serves as a legally binding contract between Paweł Tugeman (lazyridabeats) ( Licensor ) and
Exclusive LicenseExclusive License • May 26th, 2022
THIS LICENSE AGREEMENT is made on the Date Of Purchase ("effective date") by and between person(s) who purchased the instrumental (hereinafter referred to as the "Licensee")
AMENDMENT TWO TO THEExclusive License • January 3rd, 2018 • Invivo Therapeutics Holdings Corp. • Surgical & medical instruments & apparatus
This second amendment (“Amendment Two”) is made and entered into as of August 29, 2017 (the “Effective Date”) by and between Children’s Medical Center Corporation, a corporation duly organized and existing under the laws of the Commonwealth of Massachusetts and having offices located at 300 Longwood Avenue, Boston, MA (“CMCC”) and InVivo Therapeutics Corporation, a business corporation organized and existing under the laws of the State of Delaware and having its principal office at One Kendall Square, Suite B14402, Cambridge, MA 02139 (“Licensee”).
CONTRACT FORExclusive License • March 28th, 2022
This Agreement is issued solely in connection with and for Licensee's use of the Beat pursuant and subject to all terms and conditions set forth herein.
RECITALS:Exclusive License • February 10th, 2006 • Optigenex Inc. • Medicinal chemicals & botanical products • New Jersey
EXCLUSIVE LICENSEExclusive License • October 16th, 2020 • New York
Date”) and expire on December 31, 2026 unless this Agreement is renewed or sooner terminated in accordance herewith. The initial Term shall be comprised of seven (7) Years, defined as follows:
EXCLUSIVE LICENSE AGREEMENT BETWEEN MVL RIGHTS LLC AND MARVEL CHARACTERS, INC.Exclusive License • September 6th, 2005 • Marvel Enterprises Inc • Patent owners & lessors • New York
This EXCLUSIVE LICENSE AGREEMENT (“Agreement”) is made and entered into as of August 31, 2005 (“Effective Date”) by and between MVL Rights LLC, a Delaware limited liability company (“MRI”) and Marvel Characters, Inc., a Delaware corporation (“MCI”).
FIRST AMENDMENT TO THE AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENTExclusive License • February 21st, 2024 • Theratechnologies Inc. • Pharmaceutical preparations • Quebec
NOW THEREFORE IN CONSIDERATION of the above recitals and the mutual benefits to be derived hereafter, the Parties agrees as follows:
